---
status: "🟡 Draft"
category: "grant"
type: "solution-summary"
due: "2026-04-08"
priority: "P0-Critical"
tags: [ARPA-H, Delphi, grant, solution-summary, quantum-biology]
created: "2026-03-22"
updated: "2026-03-22"
---
# ARPA-H DELPHI — 6-PAGE SOLUTION SUMMARY

> [!target] SUBMISSION TARGET: ARPA-H Delphi — April 8, 2026 | Status: DRAFT | Completion: ~75%

> PI: [Name] | Co-PI: Alessandra Lanzara (UCB Physics) | Collaborator: Markus Buehler (MIT DMSE)

---

## PAGE 1 — EXECUTIVE SUMMARY

### Problem

Current cancer diagnostics miss early-stage metabolic shifts; aging biomarkers lack mechanistic grounding. Both fields operate in silos despite sharing a common quantum-biological substrate. No existing platform unifies cancer and aging detection through a single mechanistic framework.

### Insight

Cancer **amplifies** and aging **decoheres** the same four quantum protection architectures:

1. **FMO excitonic coherence** — wavelike energy transfer in light-harvesting analogs
2. **Enzyme quantum tunneling** — hydrogen and electron tunneling in metabolic enzymes
3. **Mitochondrial ETC quantum transfer** — electron tunneling through respiratory chain complexes
4. **Cryptochrome spin coherence** — radical pair spin dynamics in flavoproteins

These architectures are not independent — they share metabolite substrates (NADH, FAD, ATP, GSH) that serve as measurable indicators of quantum protection status.

### Solution

**Probius QES** label-free vibrational spectroscopy captures NADH/FAD/ATP/GSH fingerprints from 2–4 µL plasma (finger-stick). These four metabolite signatures encode opposing cancer↑ / aging↓ trajectories that are integrated into a **Quantum Protection Index (QPI)** — a composite diagnostic score.

### Impact

A unified quantum-protection diagnostic platform enabling:
- **Earlier cancer detection** through metabolic quantum amplification signatures
- **Mechanistic aging quantification** through decoherence trajectory tracking
- **Single finger-stick sample** — point-of-care, population-scalable
- **Longitudinal monitoring** — track quantum protection status over time

### Team

| Member | Institution | Role |
|---|---|---|
| PI | UCB / UCSF | Quantum biology integration, QPI development |
| Alessandra Lanzara | UCB Physics | Ultrafast mid-IR/THz spectroscopy, ground-truth validation |
| Markus Buehler | MIT DMSE | ScienceClaw × Infinite swarm AI, computational modeling |
| Clinical Partners | UCSF | Clinical translation, cohort recruitment, regulatory |

---

## PAGE 2 — TECHNICAL APPROACH

### Architecture Overview

The quantum protection framework rests on four experimentally validated architectures:

| Architecture | Mechanism | Key Evidence | Cancer Signature | Aging Signature |
|---|---|---|---|---|
| 1. FMO Coherence | Excitonic energy transfer | Engel 2007 | Enhanced coherence | Shortened lifetime |
| 2. Enzyme Tunneling | H-transfer / e⁻ tunneling | Moser-Dutton | Accelerated tunneling | Impaired tunneling |
| 3. ETC Transfer | Mitochondrial e⁻ transport | Complex I studies | Warburg amplification | NAD+ depletion |
| 4. Spin Coherence | Radical pair dynamics | Hore-Mouritsen 2016 | ROS-altered spin states | Oxidative disruption |

### Quantum Protection Index (QPI) Model

$$QPI = w_1 \cdot f(NADH) + w_2 \cdot f(FAD) + w_3 \cdot f(ATP) + w_4 \cdot f(GSH)$$

- QPI > 0 → Cancer trajectory | QPI < 0 → Aging trajectory | QPI ≈ 0 → Homeostasis
- Full mathematical framework: [[01-Core-Thesis/Quantum-Protection-Index-QPI-Model]]

### Measurement Strategy

**Probius QES** operating principles:
- Label-free vibrational spectroscopy on 2–4 µL plasma
- Spectral targets: NADH (340/460 nm), FAD (450/525 nm), GSH (thiol vibrational modes), ATP (phosphate stretches)
- Sample-to-result: < 15 minutes from finger-stick

### Top 5 Candidate Biomarkers

Selected for maximum architecture coverage and Probius readout strength — see [[00-Flight-Deck/Top-5-Delphi-Candidates]]:

1. **GSH** — 4/4 architectures, direct QES, keystone metabolite
2. **NADH** — 3/4 architectures, direct QES, primary energy currency
3. **Complex I** — 3/4 architectures, direct via NADH, electron tunneling site
4. **NRF2** — 3/4 architectures, indirect via GSH, master regulator
5. **FAD** — 3/4 architectures, direct QES, spin coherence cofactor

### Validation Pipeline

```
Finger-stick plasma → QES measurement → Spectral decomposition →
QPI scoring → Clinical correlation → Longitudinal tracking
```

### Swarm AI Integration

ScienceClaw × Infinite agents (MIT Buehler lab) provide:
- Automated literature mining across quantum biology corpus
- Hypothesis generation with testability scores
- Architecture mapping of novel candidate metabolites
- Tunneling geometry MD simulations

---

## PAGE 3 — EXPECTED OUTCOMES & MILESTONES

### Year 1: Foundation & Validation

- Establish QES baseline signatures for top 5 biomarkers in healthy controls (n=50)
- Validate cancer↑ signatures in matched tumor/normal pairs (n=30)
- Deploy swarm artifact ingestion pipeline
- Calibrate QES against Lanzara ultrafast spectroscopy ground truth

### Year 2: Cohort Expansion & QPI Refinement

- Prospective aging cohort (n=100, ages 25–85) for QPI age-correlation
- Cross-validate QES with Lanzara ultrafast pump-probe measurements
- Refine QPI algorithm — optimize weights, test architecture sub-indices
- Publish QPI framework and initial clinical correlations

### Year 3: Integration & Translation

- Integrated cancer + aging diagnostic prototype
- Clinical pilot (n=200) with blinded evaluation
- Regulatory pathway assessment (510(k) or De Novo classification)
- Multi-site reproducibility study
- Publication of full QPI validation results

### Key Milestones

| Quarter | Milestone | Deliverable | Go/No-Go Criteria |
|---|---|---|---|
| Q1 Y1 | QES calibration complete | Calibration dataset | QES-spectroscopy r² > 0.7 |
| Q2 Y1 | Healthy baseline established | n=50 reference profiles | All 4 metabolites detectable |
| Q3 Y1 | Cancer signatures confirmed | n=30 tumor/normal pairs | ≥3/5 biomarkers show cancer↑ |
| Q4 Y1 | Swarm pipeline operational | Automated artifact flow | ≥10 validated artifacts/month |
| Q1 Y2 | Aging cohort recruited | n=100 enrolled | Age distribution 25–85 |
| Q2 Y2 | QPI v1.0 released | Algorithm + weights | AUC > 0.75 on training set |
| Q3 Y2 | Cross-validation complete | QES vs Lanzara concordance | Concordance > 80% |
| Q4 Y2 | QPI publication submitted | Manuscript | Peer review initiated |
| Q1 Y3 | Prototype device | Integrated QES + QPI | Sample-to-score < 20 min |
| Q2 Y3 | Clinical pilot launched | n=200 enrolled | IRB approved, sites active |
| Q3 Y3 | Regulatory strategy finalized | FDA pre-submission | Classification determined |
| Q4 Y3 | Multi-site validation | ≥2 sites | Inter-site CV < 15% |

---

## PAGE 4 — TEAM & CAPABILITIES

### Principal Investigator

Quantum biology integration lead. Expertise in translational research bridging quantum physics and clinical medicine. Responsible for QPI model development, candidate validation pipeline, and overall project coordination. Based at UCB/UCSF.

### Co-PI: Alessandra Lanzara (UCB Physics)

World-leading ultrafast spectroscopist. Mid-IR/THz pump-probe capabilities for direct measurement of quantum coherence lifetimes in biological samples. Lab equipped with femtosecond laser systems, cryogenic sample stages, and custom spectral analysis pipelines. **Role**: Validate QES signatures against gold-standard ultrafast measurements.

### Co-PI: Markus Buehler (MIT CSAIL/CEE)

Pioneer in AI-driven materials science and biological modeling. Developer of ScienceClaw swarm intelligence platform. **Role**: Deploy AI agents for literature mining, hypothesis generation, cross-architecture pattern discovery, and predictive modeling of quantum protection signatures.

### Clinical Partner (UCSF)

Access to biobanked plasma samples (cancer cohort, aging cohort, healthy controls). IRB infrastructure for prospective sample collection. Clinical interpretation and endpoint validation.

### Institutional Resources

- **UCB**: Ultrafast spectroscopy core facility, BSL-2 labs
- **MIT**: Computational cluster, AI infrastructure
- **UCSF**: Clinical and Translational Science Institute (CTSI), shared biostatistics support

### Team Summary

| Team Member | Institution | Role | % Effort | Key Capability |
|---|---|---|---|---|
| PI | UCB / UCSF | Project lead, QPI development | 30% | Quantum biology integration |
| Alessandra Lanzara | UCB Physics | Ultrafast validation | 15% | Femtosecond spectroscopy |
| Markus Buehler | MIT CSAIL/CEE | AI/swarm modeling | 10% | ScienceClaw platform |
| Postdoc 1 | UCB | QES measurements | 100% | Spectroscopy & data analysis |
| Research Technician | UCSF | Sample processing | 100% | Biospecimen handling |
| Clinical Coordinator | UCSF | Cohort management | 50% | IRB, recruitment |

---

## PAGE 5 — BUDGET JUSTIFICATION

Total request: $X M over 3 years (placeholder — typical ARPA-H Delphi range).

> [!note] Budget figures are placeholders pending institutional F&A rate confirmation and final scope negotiation.

### Year 1 ($X): Foundation & Calibration

- **Personnel**: PI 30%, Lanzara 15%, Buehler 10%, 1 postdoc (QES measurements), 1 research technician (sample processing)
- **Equipment**: Probius QES consumables, sample collection kits
- **Travel**: Kickoff meeting, 2 cross-site visits (UCB↔MIT)
- **Compute**: Swarm compute costs (MIT cluster allocation)

### Year 2 ($X): Expansion & Validation

- **Personnel**: Same + 1 additional postdoc for clinical arm
- **Supplies**: Reagents and consumables for expanded cohort (n=100)
- **Measurements**: Lanzara lab pump-probe measurement campaigns
- **Travel**: Conference presentations (2)

### Year 3 ($X): Translation & Pilot

- **Personnel**: Same as Year 2
- **Regulatory**: Consulting (510(k) / De Novo pathway assessment)
- **Clinical**: Pilot costs (n=200 participants, phlebotomy, participant compensation)
- **Dissemination**: Publication, conference, technology transfer/licensing exploration

### Budget Summary

| Category | Year 1 | Year 2 | Year 3 | Total | Justification |
|---|---|---|---|---|---|
| Personnel | $X | $X | $X | $X | PI, Co-PIs, postdocs, technician, coordinator |
| Equipment & Supplies | $X | $X | $X | $X | QES consumables, reagents, collection kits |
| Travel | $X | $X | $X | $X | Site visits, conferences, kickoff |
| Participant Costs | — | $X | $X | $X | Compensation, phlebotomy (Y2–Y3) |
| Compute | $X | $X | $X | $X | MIT cluster for swarm agents |
| Regulatory | — | — | $X | $X | FDA pathway consulting (Y3) |
| Indirect Costs | $X | $X | $X | $X | Per institutional F&A rates |
| **Total** | **$X** | **$X** | **$X** | **$X** | |

---

## PAGE 6 — REFERENCES & APPENDICES

### Key References

1. [[06-Literature/Engel-2007-Quantum-Coherence-Photosynthesis]] — Engel GS et al. *Nature* 446:782-786 (2007). Evidence for wavelike energy transfer through quantum coherence in photosynthetic systems (FMO complex).
2. [[06-Literature/Klinman-2013-Hydrogen-Tunneling-Enzymes]] — Klinman JP. *JACS* 135:2939-2942 (2013). Hydrogen tunneling in enzyme catalysis — temperature-independent kinetic isotope effects demonstrating quantum mechanical contributions to biological catalysis.
3. [[06-Literature/Moser-2006-Electron-Tunneling-Chains]] — Moser CC, Dutton PL. *Biochim Biophys Acta* series. Electron tunneling through protein chains in mitochondrial respiratory complexes — distance and energetic dependencies.
4. [[06-Literature/Hore-2016-Radical-Pair-Mechanism]] — Hore PJ, Mouritsen H. *Annu Rev Biophys* 45:299-344 (2016). Radical pair mechanism in cryptochrome magnetoreception — spin coherence maintained in warm, wet biological systems.
5. [[06-Literature/Cao-2020-Quantum-Biology-Revisited]] — Cao J et al. *Sci Adv* 6:eaaz4888 (2020). Comprehensive review of quantum biology — covers all four architectures, current state of evidence, and future directions.

### Appendices

- **Appendix A**: Quantum Protection Index (QPI) Mathematical Framework — [[01-Core-Thesis/Quantum-Protection-Index-QPI-Model]]
- **Appendix B**: Probius QES Technical Specifications — [[04-Experiments/Probius-QES-Protocol]]
- **Appendix C**: Top 5 Delphi Candidate Profiles — [[00-Flight-Deck/Top-5-Delphi-Candidates]]
- **Appendix D**: ScienceClaw Agent Architecture — [[05-Swarm-Intelligence/ScienceClaw-Agent-Profile]]
- **Appendix E**: Sample Handling SOP — [[04-Experiments/Sample-Handling-SOP]]

---

## Submission Checklist

- [x] Pages 1–3 scaffolded with content
- [x] Pages 4–6 content drafted
- [ ] Internal review / red-team pass
- [ ] Co-PI review (Lanzara)
- [ ] Final polish and format check (6-page limit)
- [ ] **SUBMIT — April 8, 2026**

## Links

- [[01-Core-Thesis/Core-Thesis]]
- [[01-Core-Thesis/Quantum-Protection-Index-QPI-Model]]
- [[00-Flight-Deck/Top-5-Delphi-Candidates]]
- [[03-Grants/UCB-UCSF-Seed-Grant]]
- [[03-Grants/Executive-Summary]]
- [[00-Flight-Deck/Red-Team-Review-Checklist]]
